Clinical Trials Network, Ohio Valley Node U10DA013732
临床试验网络,俄亥俄谷节点 U10DA013732
基本信息
- 批准号:8606917
- 负责人:
- 金额:$ 112.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAccident and Emergency departmentAchievementAreaBilateralBuprenorphineCaringCharacteristicsClinicClinical SciencesClinical TrialsClinical Trials NetworkCollaborationsCommitCommunicationCommunitiesConduct Clinical TrialsContractsCountryDevelopmentDisciplineDoseEmergency MedicineEnsureEvaluationEvidence based practiceGoalsHealthHealth PersonnelHospitalsKentuckyKnowledgeLeadershipNational Institute of Drug AbuseOffice of Administrative ManagementOhioOpiate AddictionOpioidParticipantPatientsPharmaceutical PreparationsPrimary Health CareProtocols documentationResearchResearch PersonnelResearch TrainingSubstance abuse problemTechnology TransferTelemedicineTennesseeTestingTrainingTranslational ResearchVisionVisitWest VirginiaWorkaddictionbasedesigneffective therapyexperienceimprovedmembersubstance abuse treatmentsuccesstreatment program
项目摘要
DESCRIPTION (provided by applicant): From the beginning of its membership in NIDA's Clinical Trials Network (CTN) in 2000, the Ohio Valley Node (OVN) has been an effective, enthusiastic, and energetic node that has excelled in providing scientific and administrative leadership, in collaborating with other nodes and with NIDA and contract staff, and in disseminating information about evidence-based practices and the results of CTN studies. The OVN's Community Treatment Programs (CTPs) and its Regional Research and Training Center (RRTC) have worked together to create a node in which the CTN's goal of bilateral communication/collaboration between researchers and treatment providers has been fully realized. The success in integrating all members of this geographically dispersed node into a unified whole, together with the strong commitment of the Node PI, CTP PIs, and RRTC staff to full participation in the CTN, have enabled the OVN to be extremely productive throughout its membership in the CYN. The OVN has an experienced staff, including several RRTC and CTP PIs who have been with the OVN since its formation. The OVN continues to collaborate with a growing number of CTPs which have a variety of patient characteristics and extend over a broad geographical range now encompassing the entire Midwest (12 states) and the Upper-South states of Kentucky, Tennessee, and West Virginia. The 23 OVN CTPs, which together receive more than 100,000 patient visits a year, will contribute significantly to the number and variety of potential participants for CTN studies. The OVN administrative and management plans for the next five years capitalize on the strengths of the OVN: experience, teamwork, and varied areas of expertise (including HIV/AIDS, emergency medicine, integration of addiction treatment into primary care, and telemedicine), so the OVN can continue to contribute scientific leadership and excellence in developing/conducting CTN protocols. The OVN has detailed a research agenda designed to improve opioid dependence treatment by optimizing medication-assisted treatment and expanding office-based opioid treatment. Already cooperating actively with the four Addiction Technology and Transfer Centers (ATTCs) associated with the states covered by the OVN, the Node plans to strengthen relationships with other networks (e.g., Cincinnati Center for Clinical & Translational Science & Training).
描述(由申请人提供):自 2000 年成为 NIDA 临床试验网络 (CTN) 成员以来,俄亥俄谷节点 (OVN) 一直是一个高效、热情且充满活力的节点,在提供科学和行政领导方面表现出色,与其他节点以及 NIDA 和合同人员合作,并传播有关循证实践和 CTN 研究结果的信息。 OVN 的社区治疗计划 (CTP) 及其区域研究和培训中心 (RRTC) 共同创建了一个节点,在该节点中,CTN 的研究人员和治疗提供者之间双边沟通/合作的目标得到了充分实现。成功地将这个地理上分散的节点的所有成员整合为一个统一的整体,再加上节点 PI、CTP PI 和 RRTC 工作人员全面参与 CTN 的坚定承诺,使得 OVN 的整个成员都具有极高的生产力在CYN。 OVN 拥有一支经验丰富的员工队伍,其中包括几位 RRTC 和 CTP PI,他们自 OVN 成立以来就一直在 OVN 工作。 OVN 继续与越来越多的 CTP 合作,这些 CTP 具有各种患者特征,覆盖广泛的地理范围,目前涵盖整个中西部(12 个州)以及肯塔基州、田纳西州和西弗吉尼亚州等上南州。 23 个 OVN CTP 每年总共接待超过 100,000 名患者就诊,将大大增加 CTN 研究潜在参与者的数量和种类。 OVN 未来五年的行政和管理计划将利用 OVN 的优势:经验、团队合作和不同的专业领域(包括艾滋病毒/艾滋病、急诊医学、将成瘾治疗纳入初级保健和远程医疗),因此OVN 可以继续在开发/实施 CTN 协议方面贡献科学领导力和卓越表现。 OVN 制定了详细的研究议程,旨在通过优化药物辅助治疗和扩大基于办公室的阿片类药物治疗来改善阿片类药物依赖治疗。该节点已经与 OVN 覆盖的州的四个成瘾技术和转移中心 (ATTC) 积极合作,并计划加强与其他网络(例如辛辛那提临床与转化科学与培训中心)的关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
T John WINHUSEN其他文献
T John WINHUSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('T John WINHUSEN', 18)}}的其他基金
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10652032 - 财政年份:2022
- 资助金额:
$ 112.98万 - 项目类别:
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10621497 - 财政年份:2022
- 资助金额:
$ 112.98万 - 项目类别:
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10441986 - 财政年份:2021
- 资助金额:
$ 112.98万 - 项目类别:
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10441828 - 财政年份:2021
- 资助金额:
$ 112.98万 - 项目类别:
EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin
EMPOWER:评估通过基于网络的电子健康自我管理计划减少接受阿片类药物治疗的慢性疼痛患者吗啡当量剂量的能力:随机多站点临床
- 批准号:
10174898 - 财政年份:2017
- 资助金额:
$ 112.98万 - 项目类别:
A tailored, peer-delivered intervention to reduce recurring opioid overdoses
量身定制的、同行提供的干预措施,以减少反复出现的阿片类药物过量
- 批准号:
9015947 - 财政年份:2016
- 资助金额:
$ 112.98万 - 项目类别:
A tailored, peer-delivered intervention to reduce recurring opioid overdoses
量身定制的、同行提供的干预措施,以减少反复出现的阿片类药物过量
- 批准号:
9352799 - 财政年份:2016
- 资助金额:
$ 112.98万 - 项目类别:
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network
NIDA 临床试验网络的俄亥俄谷节点网络 (OVNN)
- 批准号:
9905868 - 财政年份:2000
- 资助金额:
$ 112.98万 - 项目类别:
Clinical Trials Network, Ohio Valley Node U10DA013732
临床试验网络,俄亥俄谷节点 U10DA013732
- 批准号:
8460234 - 财政年份:2000
- 资助金额:
$ 112.98万 - 项目类别:
The Ohio Valley Node of the Clinical Trials Network
临床试验网络俄亥俄谷节点
- 批准号:
10359825 - 财政年份:2000
- 资助金额:
$ 112.98万 - 项目类别:
相似海外基金
Impact of Recreational and Medical Marijuana legalization on cannabis use disorders, serious mental illness, and mortality outcomes among Medicaid enrolled youth
娱乐和医用大麻合法化对参加医疗补助计划的青少年大麻使用障碍、严重精神疾病和死亡率结果的影响
- 批准号:
10675915 - 财政年份:2023
- 资助金额:
$ 112.98万 - 项目类别:
ADAPT: Adaptive Decision support for Addiction Treatment
ADAPT:成瘾治疗的自适应决策支持
- 批准号:
10810953 - 财政年份:2023
- 资助金额:
$ 112.98万 - 项目类别:
Health Disparities in Utilization, Quality, and Outcomes for Three Common Ocular Conditions (HealthDOC)
三种常见眼部疾病的利用、质量和结果方面的健康差异 (HealthDOC)
- 批准号:
10559239 - 财政年份:2023
- 资助金额:
$ 112.98万 - 项目类别:
Housing Policies and their Impact on Engagement in Substance Use Treatment and Overdose Risk during the COVID-19 Pandemic
COVID-19 大流行期间的住房政策及其对参与药物滥用治疗和过量风险的影响
- 批准号:
10710054 - 财政年份:2022
- 资助金额:
$ 112.98万 - 项目类别:
Clinical effectiveness of a wearable hydration device
可穿戴水化装置的临床效果
- 批准号:
10603046 - 财政年份:2022
- 资助金额:
$ 112.98万 - 项目类别: